The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD

The Effect of Standardizing Procedures for Subcutaneous Injections of Low-molecular-weight Heparin on Patients With Cardiovascular Diseases: A Cluster Randomized Controlled Trial

Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.

This study examines the effect of standardized protocol in reducing complications for patients with cardiovascular disease.

Inclusion Criteria:

• patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
• Chinese

Exclusion Criteria:

• cognitively impaired
• unconscious
• refuse to participate